This work was financially supported by the projects of National Natural Science Foundation of China(82003991,82101844,and 82304953);Natural Science Foundation of Jiangsu Province(BK20230744,China);Jiangsu Specially Appointed Professorship Foundation(013038021001,China);Postgraduate Research&Practice Innovation Program of Jiangsu Province(KYCX22-2045 and KYCX23-2038,China).
Aberrant tumor blood vessels are prone to propel the malignant progression of tumors,and targeting abnormal metabolism of tumor endothelial cells emerges as a promising option to achieve vascular normalization and ant...